Episode
Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
- Podcast
- Breast Cancer Update
- Published
- Mar 30, 2026
- Duration seconds
- 4532
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/diabetology-in-breast-cancer-managing-hyperglycemia-in-patients-with-breast-cancer-receiving-agents-targeting-the-pi3k-akt-pten-pathway/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/breast-cancer-update-757579/diabetology-in-breast-cancer-managing-hyperglycemia-in-patients-with-breast-cancer-receiving-agents-targeting-the-pi3k-akt-pten-pathway.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Ms Jaime Carroll from Mayo Clinic in Rochester, Minnesota, Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, Dr Marie E McDonnell from Brigham and Women’s Hospital in Boston, Massachusetts, and Dr Hope S Rugo from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss the incidence, prevention and management of hyperglycemia in breast cancer patients receiving PI3K/AKT/PTEN inhibitors. CME information and select publications here .